1. The feasibility of triple-drug chemotherapy combination in older adult patients with oesophagogastric cancer: A randomised trial of the Arbeitsgemeinschaft Internistische Onkologie (FLOT65+)
   Salah-Eddin Al-Batran et al, 2013, European Journal of Cancer CrossRef
2. Chemotherapy for Advanced Gastric Cancer in Elderly Patients
   Mi-Jung Kim et al, 2014, Korean J Med CrossRef
3. Feasibility of perioperative chemotherapy with infusional 5-FU, leucovorin, and oxaliplatin with (FLOT) or without (FLO) docetaxel in elderly patients with locally advanced esophagogastric cancer
   S Lorenzen et al, 2013, Br J Cancer CrossRef
4. Adjuvant Chemotherapy in Colon Cancer: Ageism or Appropriate Care?
   Joleen Hubbard et al, 2011, JCO CrossRef
5. Cancer in the oldest old in the United States: Current statistics and projections
   Jacob D. Gundrum et al, 2012, Journal of Geriatric Oncology CrossRef
6. Simultaneous integrated boost intensity-modulated radiotherapy in esophageal carcinoma
   Wei-Wei Yu et al, 2014, Strahlenther Onkol CrossRef
7. Changes in Age, Stage Distribution, and Survival of Patients with Esophageal Adenocarcinoma over Three Decades in the United States
   Putao Cen et al, 2012, Ann Surg Oncol CrossRef
8. Palliative chemotherapy for gastroesophageal cancer in old and very old patients: A retrospective cohort study at the National Center for Tumor Diseases, Heidelberg
   Anne Katrin Berger, 2015, WJG CrossRef
9. Magenkarzinom beim alten und geriatrischen Patienten
   Nadine Schulte et al, 2017 CrossRef
10. Management of gastric cancer in older adults.
    Christiana Matthaiou et al, 2017, J Geriatr Oncol CrossRef
11. Elevated Serum Vitamin B12 Levels as a Prognostic Factor for Survival Time in Metastatic Cancer Patients: A Retrospective Study
    Hye Kyung Oh et al, 2017, Nutrition and Cancer CrossRef
12. A randomized phase II study of S-1 versus capecitabine as first-line chemotherapy in elderly metastatic gastric cancer patients with or without poor performance status
    Mi-Jung Kim et al, 2018, Pharmacogenetics and Genomics CrossRef
13. Safety and Efficacy of Dose-dense Chemotherapy with TCF Regimen in Elderly Patients with Locally Advanced or Metastatic Gastric Cancer
    Wanda Liguigli et al, 2017, Tumori Journal CrossRef
14. Magenkarzinom beim alten und geriatrischen Patienten
    Nadine Schulte et al, 2018 CrossRef
15. Efficacy and safety of chemotherapy in older versus non-older patients with advanced gastric cancer: A real-world data, non-inferiority analysis
    Laura Visa et al, 2017, Journal of Geriatric Oncology CrossRef
16. CHEMOTHERAPY IN ELDERLY PATIENTS WITH STOMACH CANCER
    O. A. Koroleva et al, 2018, Zlokač. opuholi CrossRef
17. Management of Locally Advanced and Metastatic Esophageal Cancer in the Older Population
    Dara Bracken-Clarke et al, 2018, Curr Oncol Rep CrossRef
18. Treatment of Patients with Advanced Gastroesophageal Adenocarcinoma: Does Age Matter?
    Sylvie Lorenzen et al, 2019, Drugs Aging CrossRef
19. Epidemiology of Gastrointestinal Disease
    Julia B. Greer et al, 2012 CrossRef
20. Yaşlı metastatik mide kanserli hastalarda tek başına oral kapesitabin ile platin kombinasyonlarının karşılaştırılması
    Serkan Değirmencioğlu et al, 2019 CrossRef
21. Esophageal Cancer
    Jennifer Chuy et al, 2020 CrossRef
22. Toxicity and survival outcomes in older adults receiving concurrent or sequential chemoradiation for stage III non-small cell lung cancer in Alliance trials (Alliance A151812)
    Ronald J. Maggiore et al, 2020, Journal of Geriatric Oncology CrossRef
23. Towards Personalization in the Curative Treatment of Gastric Cancer
    Astrid E. Slagter et al, 2020, Front. Oncol. CrossRef
24. Geriatrische gastrointestinale Onkologie: Ösophagus, Magen, Dickdarm
    Jochen Rudi, 2021, Gastroenterologe CrossRef
25. Nutritional Support Indications in Gastroesophageal Cancer Patients: From Perioperative to Palliative Systemic Therapy. A Comprehensive Review of the Last Decade
    Giulia E.G. Mulazzani et al, 2021, Nutrients CrossRef
26. Esophageal Cancer
    Jennifer Chuy et al, 2021 CrossRef
27. A case-control study of a combination of single nucleotide polymorphisms and clinical parameters to predict clinically relevant toxicity associated with fluoropyrimidine and platinum-based chemotherapy in gastric cancer.
    Miguel Cordova-Delgado et al, 2021, BMC Cancer CrossRef
28. Advanced oesophago-gastric adenocarcinoma in older patients in the era of immunotherapy. A review of the literature
    C. de la Fouchardiere et al, 2021, Cancer Treatment Reviews CrossRef
29. Impact of the Cancer and Aging Research Group score and treatment intensity on survival and toxicity outcomes in older adults with advanced noncolorectal gastrointestinal cancers
    Tomohiro F. Nishijima et al, 2022, Cancer CrossRef
30. Older versus younger adults with gastric cancer receiving perioperative treatment: Results from the CRITICS trial.
    Astrid E Slagter et al, 2020, Eur J Cancer CrossRef
31. Clinical utility of geriatric assessment tools in older patients with gastrointestinal cancer
    Ayako Doi et al, 2023, Front. Oncol. CrossRef
32. Small-molecule inhibitors targeting FOXM1: Current challenges and future perspectives in cancer treatments
    Sanjeev Raghuwanshi et al, 2023, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer CrossRef
33. Hepatic arterial infusion chemotherapy and trastuzumab in gastric cancer with liver metastases: a case report
    Hui-qin Li et al, 2023, Front. Oncol. CrossRef
34. Assessing Frailty in Gastrointestinal Cancer: Two Diseases in One?
    Ishan Patel et al, 2024, Curr Oncol Rep CrossRef
35. Outcomes in older adults with metastatic esophageal and gastric carcinoma treated with palliative chemotherapy
    Xin Wang et al, 2024 CrossRef
36. Comparision of Perioperative Fluoropyrimidine, Docetaxel And Oxaliplatin Regimen with Adjuvant Fluoropyrimidine and Oxaliplatine Regimen In Operable Gastric Cancer Patients
    Aslı Yıldırım et al, 2024 CrossRef